Medium-term effectiveness of L-thyroxine treatment in idiopathic dilated cardiomyopathy

The American Journal of Medicine
P MoruzziP G Agostoni

Abstract

In dilated cardiomyopathy, short-term administration of L-thyroxine (100 micrograms/ day) improves cardiac and exercise performance without changing the heart's adrenergic sensitivity. The aim of this study was to test the medium-term (3 months) efficacy of L-thyroxine (10 patients) compared with placebo (10 patients) and to find out whether later effects are obtainable. Echocardiographic parameters in the control state and during acute changes of left ventricular afterload, cardiopulmonary exercise test, and hemodynamic parameters, including cardiac beta 1 responses to dobutamine, were obtained before and at the end of treatment. Significant (P < 0.05) changes were observed only with the active drug. After L-thyroxine, patients did not show evidence of chemical hyperthyroidism, despite the increase in thyroxine and the reduction in thyroid-stimulating hormone plasma levels. Cardiac performance improved, as shown by the increase in the left ventricular ejection fraction and rightward shift of the slope of the relation left ventricular ejection fraction/end-systolic stress. Resting cardiac output increased, and the left ventricular diastolic dimensions and systemic vascular resistances decreased. The responses of cardiac output ...Continue Reading

References

Jul 1, 1991·The Journal of Clinical Endocrinology and Metabolism·G MintzI Klein
Jun 1, 1990·The American Journal of Medicine·W H Dillmann
Jun 1, 1990·The American Journal of Medicine·I Klein
Sep 1, 1990·The Journal of Clinical Investigation·J R MinottiM V Icenogle
Jul 1, 1987·The Journal of Clinical Investigation·D KimJ D Marsh
Jun 1, 1986·Journal of Applied Physiology·W L BeaverB J Whipp
Apr 1, 1984·Journal of Applied Physiology: Respiratory, Environmental and Exercise Physiology·J O Holloszy, E F Coyle
Sep 27, 1984·The New England Journal of Medicine·J N CohnT Rector
Dec 7, 1995·The New England Journal of Medicine·J D KlempererK Krieger
Aug 1, 1994·British Heart Journal·H Drexler
May 1, 1993·Circulation·R PolikarP Nicod
Jan 1, 1996·Progress in Cardiovascular Diseases·J D KlempererI Klein

❮ Previous
Next ❯

Citations

Jul 19, 2011·Journal of Thyroid Research·Iordanis MourouzisGiorgio Iervasi
Oct 1, 2014·Thyroid : Official Journal of the American Thyroid Association·Jacqueline JonklaasUNKNOWN American Thyroid Association Task Force on Thyroid Hormone Replacement
Feb 8, 2006·Canadian Journal of Physiology and Pharmacology·Jarmila MachackovaNaranjan S Dhalla
Feb 24, 2007·Vascular Health and Risk Management·Alessandro Pingitore, Giorgio Iervasi
Jan 7, 2009·Heart Failure Reviews·Wolfgang Dillmann
Apr 16, 1998·Endocrinology and Metabolism Clinics of North America·I Klein, K Ojamaa
Jun 2, 2007·Heart Failure Reviews·Dennis V Cokkinos, Costas Pantos
Jul 30, 2010·Heart Failure Reviews·Constantinos PantosDennis V Cokkinos
Aug 4, 2001·Thyroid : Official Journal of the American Thyroid Association·M M CiullaP Beck-Peccoz
Aug 18, 2006·Current Heart Failure Reports·Ursula Maria Schmidt-Ott, Deborah Davis Ascheim
Feb 15, 2001·The New England Journal of Medicine·I Klein, K Ojamaa
May 11, 2013·Endocrinología y nutrición : órgano de la Sociedad Española de Endocrinología y Nutrición·Jorge Curotto GrasiosiRicardo J Esper
Dec 17, 2009·Vascular Pharmacology·Kaie Ojamaa
Nov 18, 2009·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·G CiniG Iervasi
Jun 15, 2015·The Lancet. Diabetes & Endocrinology·Eric FliersAnita Boelen
May 6, 2008·Pharmacology & Therapeutics·Constantinos PantosDennis Cokkinos
Apr 24, 2008·The Journal of Steroid Biochemistry and Molecular Biology·Constantinos PantosDennis V Cokkinos
Oct 23, 2010·European Journal of Clinical Investigation·Theodora A PappaMaria Alevizaki
Feb 8, 2005·The American Journal of Medicine·Alessandro PingitoreGiorgio Iervasi
Oct 29, 2008·Annales d'endocrinologie·M François, B Delemer
Apr 9, 1999·Journal of Cardiac Failure·F S MalikC H Van Meter
Mar 7, 1998·American Heart Journal·M Gomberg-Maitland, W H Frishman
Dec 4, 2014·Clinical Medicine : Journal of the Royal College of Physicians of London·Avais Jabbar, Salman Razvi
Oct 30, 2001·The Veterinary Journal·M BorgarelliJ Häggström
Jan 18, 2011·Annales d'endocrinologie·F LucaT Brue
Nov 5, 2016·Nature Reviews. Cardiology·Avais JabbarSalman Razvi
Mar 21, 2017·Thyroid : Official Journal of the American Thyroid Association·Ari J WassnerStephen A Huang
Aug 10, 2010·Arquivos brasileiros de endocrinologia e metabologia·Laura S Ward
Oct 21, 2000·Thyroid : Official Journal of the American Thyroid Association·Y ShaoF Ismail-Beigi
Jun 18, 1998·American Heart Journal·C M O'ConnorK Swedberg
Jan 26, 2018·Journal of Cardiovascular Development and Disease·Marco Luciani, Federica Del Monte
Sep 4, 2013·Nature Reviews. Nephrology·Christiaan L MeuweseJuan J Carrero
Oct 8, 2009·Circulation. Heart Failure·Luigi Saccà
Jul 28, 2010·Circulation·Anthony Martin Gerdes, Giorgio Iervasi
Jan 18, 2014·Endocrine Reviews·Bernadette Biondi, Leonard Wartofsky
Jan 6, 2005·Endocrine Reviews·George J Kahaly, Wolfgang H Dillmann
May 10, 2001·The Journal of Clinical Endocrinology and Metabolism·G d'AmatiF S Celi
May 24, 2006·The Journal of Biological Chemistry·Agnes Kenessey, Kaie Ojamaa
Aug 27, 2013·Current Opinion in Endocrinology, Diabetes, and Obesity·Alan P Farwell
Sep 16, 2014·Expert Review of Cardiovascular Therapy·Laura SabatinoAlessandro Pingitore
May 15, 2020·Journal of Clinical Pharmacy and Therapeutics·Yihao ChenJunji Wei

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiomyopathy

Cardiomyopathy is a disease of the heart muscle, that can lead to muscular or electrical dysfunction of the heart. It is often an irreversible disease that is associated with a poor prognosis. There are different causes and classifications of cardiomyopathies. Here are the latest discoveries pertaining to this disease.